Introduction
LIS1 is a 46 kDa protein involved in synapse formation, synapse modulation, and neuronal migration, which plays a crucial role not only during brain development but also in adult stage. LIS1 is encoded by
PAFAH1B1 gene, located in the chromosome 17, and formed by two functional domains. LisH domain is located in the N-terminus portion and mediates the interaction with other LIS1 peptides to produce a LIS1 homodimer, the functional form of the protein. The following portions are a coiled-coil domain with structural function and WD40 domain, sited in the C-terminus, which mediates the interaction with target proteins (Reiner et al.
2002). LIS1 is a regulator of the binding of dynein to the microtubules. Dynein is a molecular motor which regulates the dynamics and stability of microtubules during cell growth and movement, and also with the transport of cargos along them. These mechanisms are the ones supposed to be altered in classic individuals with lissencephaly since they are directly involved in neuronal migration, axon growth and synapse formation and also other partners from the same cascade, such as DXC, produce other forms of lissencephaly with similar pathophysiology (Wynshaw-Boris and Gambello
2001). However, LIS1 also acts as a non-catalytic regulatory subunit of the acetyl-hydrolase of the platelet activating factor (PAF-AH), which regulates the levels of the platelet aggregation factor (PAF) (Hattori et al.
1994). Some studies also suggest that PAF can be involved in neuronal migration and synaptic modulation (Clark et al.
1992; Gopal et al.
2009).
Alterations in the encoding and regulatory sequence of
LIS1 have been largely described as the cause of classic lissencephaly, a drastic neurological disorder characterized by the alteration of number and size of brain gyri and sulci (pachygyria) or its complete absence (agyria) (Lo Nigro et al.
1997). One hallmark of the
LIS1 dysfunction is the deep disorganization of the cortical structure, which is commonly reflected in the loss of the typical six-layering pattern due to disrupted neuronal migration during developmental stages. On the other hand, the functional hallmark of classic lissencephalic brains is the recurrent apparition of intractable and fast-propagated epileptic seizures, which produce a progressive cognitive decline, compromising the quality of life and life expectancy of the patients (Dobyns
1993).
A wide variety of alterations in
LIS1 have been described in different cohorts of classic lissencephaly patients (Saillour et al.
2009), ranging from point mutations to prominent deletions affecting encoding or regulatory regions of the gene; however, the relationship among different alterations in the LIS1 protein and the pathophysiology of the classic lissencephaly is not fully understood. Previous investigations in murine models have revealed some details about how neuronal networks are affected by LIS1 dysfunction. Extracellular recordings “in vivo” in a murine model of
LIS1 dysfunction showed that a 50% reduction in the LIS1 protein dosage produced an increase of excitability in several hippocampal networks, such as the dentate gyrus and the CA1 area, leading to the appearance of epileptic-like activity in both regions (Fleck et al.
2000; Dinday et al.
2018). Additional work in the same model revealed that this over-excitation is the consequence of an increased probability of release of glutamate vesicles from perforant pathway presynaptic terminals on granule cells of the dentate gyrus, and from Schaffer collaterals on CA1 pyramidal neurons (Greenwood et al.
2009; Hunt et al.
2012). This loss of excitatory control might be produced by the overall disruption of the cellular structure of these hippocampal regions, given that many glutamatergic and GABAergic neurons were ectopically positioned as a result of aberrant neuronal migration during the development (Hirotsune et al.
1998; Fleck et al.
2000; Wang and Baraban
2007; Jones and Baraban
2007).
In the present work, we study the properties of synchronic epileptiform activity evoked by inhibition of GABA
A receptors in the neocortex of the
Lis1/sLis1 mice. This mouse is a model of LIS1 dysfunction which presents a complete deletion of the LisH domain (Cahana et al.
2001); this LIS1 mutation is similar to that of a lissencephaly patient with an in-frame N-terminal deletion (Fogli et al.
1999), but it is different from the mutations of the Lis1 ± mouse described by Hirotsune et al. (
1998); the developmental alterations detected in the
Lis1/sLis1 and Lis1 ± models are also different (Cahana et al.
2001; Hirotsune et al.
1998). In the
Lis1/sLis1 model, it has been shown the presence of abnormalities in the inhibitory synaptic transmission in the cerebral cortex, including alterations in GABA
A receptors (Valdés-Sánchez et al.
2007). Our objective is to study the properties and propagation of epileptiform discharges along layer 2/3 in the disinhibited cingulate cortex of the
Lis1/sLis1 model. The experiments were done using electrophysiological recordings in brain slices of
Lis1/sLis1 and wild type animals. Our results indicate that the lack of LisH in one allele produces a clear slowing down of the propagation of the epileptiform activity along the layer 2/3 of the anterior cingulate and the retrosplenial cortex, and suggest that abnormalities of the synaptic transmission mediated by glutamate receptors could be implicated in this effect. We show also that there are no differences between wild type and mutant animals in the sensitivity to bicuculline of the generation of epileptiform discharges, and that there are abnormalities of the spontaneous EPSCs recorded in pyramidal neurons of mutant animals (lower frequency and higher peak amplitude). Overall, these results indicate that the dysfunction of the
LIS1 gene causes abnormalities in the properties of epileptiform discharges and in their propagation along the layer 2/3 of these cortical areas.
Methods
Animals and slice preparation
Experiments were done in brain slices prepared from male
Lis1/sLis1 mice (Cahana et al.
2001). Mice (14–16 postnatal days) were maintained, managed, and sacrificed following the international laws and policies (Spanish Directive “RealDecreto1201/2005”; European Union Directive 2010/63/UE). All protocols were approved by the Ethical Committee for Experimental Research of the Universidad Miguel Hernández (code: 2018/VSC/PEA/0035). Mice were genotyped before performing the experiments by PCR. A ≈ 750 bp DNA fragment was amplified from mutant mice tissue sample lysate with the following primers: 3’GGTGGCAGTGTTGAGATG CCTAGCC5’ and 5´GCATTCCTGTAATCCAGTACCTGG 3´. Amplification was performed for 35 cycles with single initial denaturalization step of 94° for 5 min. Each cycle was composed by a denaturalization step of 94° for 40 s, hybridization step of 60° for 45 s and a polymerization step of 72° for 10 s.
Animals were killed by cervical dislocation, decapitated, and their brains were quickly removed and sliced (400 µm, coronal plane) with a vibratome (LeicaVT1000) submerged in ice-cold cutting solution (composition in mM: NaCl, 124; KCl, 2.5; PO4H2Na, 1.25; MgCl
2, 2.5; CaCl
2, 0.5; NaCO
3H, 26; glucose, 10; pH 7.4 when saturated with 95% O
2 and 5% CO
2). The slices were transferred to a modified artificial cerebro-spinal fluid (mACSF) with high extracellular potassium for enhanced excitability (composition in mM: NaCl, 124; KCl, 5; PO4H2Na, 1.25; MgCl
2,1; CaCl
2, 1.2; NaCO
3H, 26; glucose, 10; pH 7.4 when saturated with 95% O
2 and 5% CO
2); slices were incubated in this solution at 37 ºC during 30 min. and then remained at room temperature until recordings; recordings were obtained at least 60 min after preparing the slices. Anterior cingulate cortex (ACC) and retrosplenial cortex (RSC) slices were selected by their position along the rostro-caudal axis according to the mouse brain atlas by Paxinos and Franklin (
2001). We considered ACC slices those placed between 1.10 and 0.14 mm from the bregma, and RSC slices those placed between − 1.06 and − 2.06 mm from the bregma.
Electrophysiological recordings
For recording, one slice was placed in the recording chamber where it was perfused with mACSF at ≈3 ml/min (33–34 °C). For extracellular recordings, bicuculline (10 µM) was added to the ACSF (except in the experiments of bicuculline dose–response relationship shown in Fig.
2). Extracellular recordings were done with glass pipettes pulled of borosilicate glass (1.5 mm o.d., 0.86 mm i.d., with inner filament) and filled with mACSF (3–6 MOhm). In each slice a single electrode was successively placed in different recording positions within layer 2/3 to obtain electrophysiological recordings, as shown in the Results section. Local field potentials were recorded with a MultiClamp 700B amplifier (Axon Instruments, Molecular Devices, USA), filtered at 5 kHz and digitized at 20 kHz (Digidata 1200B or 1440A Axon Instruments, Molecular Devices, USA). Bicuculline, GYKI53655, cyclothiazide, and CNQX were obtained from Sigma–Aldrich (USA). Extracellularly recorded responses in layer 2/3 were evoked by applying electrical stimuli to layer 1 using bipolar concentric electrodes. Responses were evoked by square current pulses (0.1 ms of duration) whose amplitude was adjusted to 2 × the threshold intensity. The latency of the evoked responses was calculated from the onset of the stimulus artifact to the time at which the response was 10% of its peak amplitude. The frequency of the oscillatory post-discharges was measured from the autocorrelogram computed during an interval of 250–500 ms of regular oscillatory activity; the frequency was measured from the interval between the 1st (at 0 ms, with the highest autocorrelation) and the 2nd peaks of the autocorrelogram (see below, Fig.
3).
Single neuron electrophysiological parameters were studied using somatic whole-cell intracellular recordings from pyramidal neurons in layer 2/3 of the dorsal agranular RSC (aRSC). Pyramidal neurons were selected by the shape of the soma and the prominent apical dendrite as seen under the microscope with DIC optics. Intracellular recordings were obtained with patch pipettes made of borosilicate glass that had 3–5 MOhms when filled with the intracellular solution (composition in mM: 130 potassium gluconate, 5 KCl, 5 NaCl, 5 EGTA, 10 HEPES, 2 Mg-ATP, 0.2 Na-GTP; pH 7.2 adjusted with KOH; 285–295 mOsm). Resting membrane potential was measured after achieve whole-cell configuration. Series resistance was compensated in current-clamp mode with the bridge balance tool of the Multiclamp. Passive responses and action potential firing were obtained in current-clamp configuration by applying a protocol of consecutive current square pulses (− 150 pA to 200 pA; 1 s of duration, 25 pA of increment). Membrane input resistance was calculated from the voltage deflection caused by small (− 25 to − 50 pA) hyperpolarizing current pulses. Action potential (AP) threshold was estimated as the potential level at which there was a clear abrupt increase in the slope. AP amplitude was measured from action potential threshold. AP duration was measured at 50% from the AP peak. Action potential after-hyperpolarization (AHP) peak amplitude was measured from AP threshold. AHP duration was measured from the peak to the 50% of the peak amplitude. Spontaneous postsynaptic excitatory currents (sEPSCs) were recorded in voltage-clamp configuration, holding the membrane potential of the cell at − 68 mV (equilibrium potential for Cl–- calculated from the extra and intracellular concentrations). Spontaneous synaptic currents detection and analysis were performed using WinEDR 3.9.1 software (Dr. J. Dempster, University of Strathclyde, Glasgow UK). All drugs used in the experiments were added to the mACSF at the specified concentrations from concentrated stocks prepared in water (bicuculline, GYKI53655, and CNQX; stocks at 1000 × the final maximum concentration) or in DMSO (cyclothiazide; stock 50 mM).
Lentivirus injection and immunofluorescence
Postnatal P4 mice were anesthetized and injected with a lentivirus that expresses GFP under the promotor of CaM kinase IIa (Lv-CkIIa-GFP; SignaGene; SL100307). At P14, the injected and non-injected mice were perfused with paraformaldehyde (PFA) 4% in PBS, and the brains were maintained in PFA 4% overnight at 4 ºC. The brains were embedded in agarose at 4% and cut in slices using a vibratome (100 µm of thickness). The slices were incubated in PBST with 1% of BSA and 10% of lysine and incubated with the primary antibodies overnight at 4ºC: chicken anti GFP (1:200, AVES; GFP-1020), mouse anti GluA2 (1:500, Fisher; 32-030-0), mouse anti-GluA1 (1:500, Rockland, 200-301-D61), rabbit anti-GluK5 (1:500, Abcam, ab32672), and rabbit anti GluK1 (1:500, Abcam, ab67316). The slices were washed with PBST and incubated with the secondary antibodies, anti-chicken-FITC (Sigma; F8888) and anti-mouse-Alexa 594 (Molecular Probes; A11032), anti-mouse-Alexa 488 (Molecular probes; A11019), and anti-rabbit-Alexa 488 (Molecular Probes; A21206), and DAPI (nuclear marker). The slices were mount with mowiol-NPG and the pictures were taken with the confocal microscope Leica SPEII.
Western blot
The proteins were extracted from fresh brain tissues (ACC and RSC) from postnatal 16 mice after decapitation. The extraction was made with RIPA buffer (Millipore; 20–188) in azote and sonicated later. The total amount of proteins was detected with Pierce BCA protein assay kit (Thermo Scientific; 23225). After denaturalization (at 92 ºC, 10 min with β-mercaptoethanol) 20 µg of proteins of each sample were loaded on SDS–polyacrylamide gel (12%) and electrophoresed followed by wet transfer in nitrocellulose blotting membrane (Amersham; 10600007). The membranes were incubated with primary antibodies overnight at 4 ºC (with TBST and BSA 5%): rabbit GluA2 (1:4000, Fisher; AB1768IMI), mouse anti-GluA1 (1:1000, Rockland, 200-301-D61), rabbit anti-GluK5 (1:1000, Abcam, ab32672), and mouse GAPDH (1:10,000, GeneTex; GTX627408). The membranes were washed with TBST and incubated with the secondary antibodies conjugated with HRP: anti-rabbit (1:4000, Vector; BA-1000) and anti-mouse (1:4000, Vector; BA-9200). The membranes were treated with Immobilon Forte (Millipore; WBLU0100) and exposed in dark room. Images were taken with the Amersham Bioimager 680 and to analyze the ratio of gray values between samples Image J was used. The protein level was expressed in arbitrary units (A.U.) calculated as the quotient between the area of the GluA2 band over the area of the GAPDH band.
Statistics
Data are given as mean ± SEM and the number of cases. Statistical analysis was made with SigmaStat3.2 (SystatSoftwareInc., USA). Comparisons were made with the Student’s
t test or the Mann–Whitney Rank Sum test (when sample values did not follow a normal distribution as checked with the Kolmogorov–Smirnov test). For percentage comparison in Fig.
3C, chi-squared (
χ2) test was used. Statistical significance values were depicted using the following code: (*)
p value < 0.05; (**)
p value < 0.01; (***)
p value < 0.001.
Discussion
LIS1 is a widely expressed protein involved in several cellular functions (Reiner and Sapir
2013). Since the isolation of
LIS1 gene (Reiner et al.
1993), a bunch of heterogeneous alterations along the encoding sequence have been described in lissencephalic patients (Saillour et al.
2009; Chong et al.
1997; Uyanik et al.
2007), ranged from point mutations to big deletions. Despite the poor knowledge about how
LIS1 dysfunction affects neuronal networks, it has been proposed that recurrent intractable epileptic crisis, a hallmark of lissencephaly, are the consequence of a deficit in the inhibitory control of these networks (Dobyns
2010).
In this work, we performed a set of experiments in the cingulate cortex of
Lis1/sLis1 mice, a model lacking the LisH domain in heterozygosis, to understand the impact of this genetic context in the properties of the neocortical networks implicated in the generation of epileptiform activity. The use of GABA
A blockers, such as bicuculline, to induce epileptiform electrical activity that propagates along the cortex has been described and studied for years, and the pharmacological disinhibition is a widely accepted model of epileptiform activity in the cerebral cortex (Chagnac-Amitai and Connors
1989; Pinto et al.
2005; see a review in Avoli et al.
2002). The use of bicuculline in our experiments allowed us to study epileptiform electrical activity in the
Lis1/sLis1 cortex, but it prevented us to study the contribution of the GABAergic transmission to the alterations that we describe here. Our finding that spontaneous epileptiform discharges appeared with similar frequency suggests that the excitability of cortical neural circuits was similar in
Lis1/sLis1 and WT cortices. This conclusion is reinforced by the finding of a similar EC
50 of bicuculline for the generation of EA. However, we cannot discard the presence of subtle differences in excitability that were occluded by the partial blockage of GABA
A receptors by bicuculline used to evoke EA. Thus, our results indicate that the neuronal mechanisms controlling the emergence of epileptic activity are preserved and that the GABAergic mechanisms that prevent the apparition of EA are also preserved in the
Lis1/sLis1 cortex, since the same concentration of bicuculline produced the same frequency of EA events in WT and
Lis1/sLis1 cortex.
The oscillatory component of the EA had a lower frequency but the same overall duration in WT and
Lis1/sLis1 slices. This kind of oscillatory activity is caused by complex interactions between neuronal intrinsic electrophysiological properties and synaptic activity (Avoli et al.
2002; De Curtis et al.
2012). We show that some intrinsic properties of layer 2/3 pyramidal neurons that participate in the generation of oscillatory activity (membrane resting potential, membrane resistance, and action potential threshold) were similar in both genotypes; this discards the alterations of intrinsic neuronal properties as the cause of the lower frequency and suggests that its cause could be the presence of synaptic alterations, given that it has been described the modulation of this type of oscillatory post-discharges by AMPA receptors (Castro-Alamancos and Rigas
2002).
An important finding arise from the study of EA propagation along the cingulate cortex. Their propagation was slower, both in the anterior cingulate cortex and in the retrosplenial cortex; also, in the RSC the onset of EA in the contralateral hemisphere after its propagation through the corpus callosum took longer time. This finding clearly points to the presence of abnormalities in the cortical neuronal circuits supporting both the propagation of EA and its initiation in the neocortex, because the long latencies of the responses recorded in the contralateral cortex are due mostly to the process of EA building-up and not to the propagation through the corpus callosum, which takes much shorter times (Rovira and Geijo-Barrientos
2016; Sempere-Ferrández et al.
2018). The propagation of EA across neocortex in conditions of partial blocking of GABA
A receptors depends mostly on excitatory glutamatergic synapses (probably acting by AMPA receptors) connecting pyramidal neurons in the layer 2/3 (Pinto et al.
2005), but alterations in the intrinsic electrophysiological properties of the cortical pyramidal neurons could be also implicated in this slow propagation. Somatic whole-cell recordings showed that, in concordance with previous studies obtained from parietal cortex in the
Lis1/sLis1 model (Valdés-Sánchez et al.
2007), there were not alterations in the intrinsic properties related with the neuronal excitability, such as resting membrane potential, input membrane resistance, or action potential threshold. This was similar to the finding of absence of alterations of the intrinsic properties of hippocampal glutamatergic (Hunt et al.
2012) or GABAergic neurons (Jones and Baraban,
2007) in a mouse model lacking one allele of LIS1. Altogether, these findings suggest that LIS1 dysfunction does not have impact on the neuron electrophysiology despite its important role in different cellular processes.
We detected a reduced frequency and an increased amplitude of the sEPSCs recorded in pyramidal neurons of
Lis1/sLis1 cortex in comparison with pyramidal neurons from WT cortex. This finding is contrasting with the results by Greenwood et al. (
2009), who showed, in a different
Lis1 mutant mouse (the heterozygous
Lis1ex6neo−8), a large increase of the frequency of both spontaneous and miniature EPSC, but without changes in their peak amplitude; these abnormalities are probably due to an enhancement of glutamate transmission. In our model, the results with GYKI and CNQX suggest also the presence of abnormalities in the glutamate mediated synaptic transmission. We have not found alterations in the distribution or in the level of some glutamate receptor subunits (GluA1, GluA2, GluK1, and GluK5) studied with immunohistochemistry and western blot; this suggest that there are not structural differences in AMPA or kainate receptors related to these subunits, but other possibilities remain open, given the number of cellular processes in which the gen
LIS1 is involved. The lower sEPSC frequency could be caused by an altered overall network activity or by synaptic abnormalities (a decreased probability of transmitter release or synaptic failures); on the other side, the increased size of sEPSCs could be related to functional alterations of glutamate receptors. Since our experiments were done in the presence of bicuculline, with an enhanced neuronal excitability, the mechanisms underlying the decreased frequency of sEPSC could be due to alterations in transmitter release and/or in the functional properties of glutamate receptors.
Since the propagation of EA depends on excitatory glutamatergic transmission between pyramidal neurons that is highly dependent on AMPA type receptors (Alefeld et al.
1998; Pinto et al.
2005) we next hypothesized that the reduced velocity of propagation could be a consequence of alteration in the properties of these receptors. We tested this possibility by studying the modulation of the latency of EA discharges by drugs acting on AMPA / kainate receptors: GYKI 53,655, a selective blocker of AMPA receptors (Paternain et al.
1995), CNQX, a blocker of AMPA/kainate receptors and cyclothiazide, a positive modulator of AMPA receptors. Our findings suggest a different implication of AMPA and kainate receptors mediated transmission in the longer latencies observed in the pACC and aRSC of
Lis1/sLis1 animals. In the pACC both GYKI 53,655 and CNQX produced a larger increase in latency in
Lis1/sLis1 than in WT cortex; this indicates that abnormalities in synaptic transmission mediated by AMPA receptors would be sufficient to explain this result (although an effect due to alterations on both, AMPA and kainate receptors cannot be excluded by the results). In contrast, in the aRSC only the CNQX induced larger latencies in
Lis1/sLis1 slices, which suggest that in this cortical area the increased in latency observed in
Lis1/sLis1 animals could be caused mostly by alterations in the kainate receptor mediated transmission. The larger average peak amplitude of the sEPSC's recorded in the aRSC should be against a decreased velocity of propagation of EA, but the increased frequency indicates a facilitated synaptic transmission, which should increase the propagation velocity. The final propagation velocity should be the result of the balance of this two changes, without ruling out other mechanisms, such as alterations in the summing of synaptic responses in neurons). We do not have a clear explanation of the lack of effect of CTZ on the latencies of the propagating EA, but this finding could indicate that the strong inhibition of the desensitization of AMPA receptors caused by CTZ (Fucile et al.
2006) do not play a role in the propagation of electrical activity in this brain region, although CTZ reduce the latency of propagated activity in the spinal cord (Bonnot et al.
2009). The levels of glutamate receptors expressing the GluA2 subunit were not altered in the
Lis1/sLis1 cortex, as shown by immunohistochemistry and western blot; this finding discards a change in the level of these receptors as the cause of the differences in propagation of EA, but other possibilities remain open.
Finally, other interesting point is the heterogeneous phenotypical severity along the cingulate cortex. Data from latency of propagation (longer latencies in the contralateral hemispheres only in RSC) and possible glutamate receptor types implicated reflect that the posterior cingulate region (the retrosplenial cortex) displays a different phenotype in the
Lis1/sLis1 mouse. An explanation for this fact could be that LIS1 function might be more relevant in caudal regions, given that during cortical development, LIS1 is more expressed in caudal than in rostral regions (Escámez et al.
2012). These two areas of the cingulate cortex present some differences in structure and connectivity (Vogt and Paxinos
2012) and, therefore, they could be differentially affected.
Our main findings in the disinhibited cingulate cortex of Lis1/sLis1 mice show a normal overall excitability and the presence of alterations in the epileptiform activity (a decreased frequency of oscillatory post-discharges and a slow propagation along layer 2/3); these findings suggest the presence of some type of network alteration since the intrinsic electrophysiological properties of the pyramidal neurons were not altered. Our data about glutamate receptors point to alterations of AMPA/kainate receptors that should be studied further, but alterations of other circuit mechanisms should also be investigated.
The above results and conclusions were obtained in a model lacking the LisH domain similar to a human case of lissencephaly (Fogli et al.
1999). Although early clinical studies suggest a certain genotype–phenotype relationship among LIS1 alterations and clinical profiles (Cardoso et al.
2000), this has been discarded by more accurate studies (Saillour et al.
2009; Uyanik et al.
2007). In fact, in the largest clinical characterization of lissencephalic patients (Saillour et al.
2009), authors described diverse LisH alterations in patients presenting a wide range of phenotypical profiles. It has been suggested by some authors that partial deletions and punctual mutations in the LisH domain might be related to less severe forms of lissencephaly (Cardozo et al. 2000), although that observation is debated (Saillour et al.
2009). According to that, our results revealed that, although the LisH domain deletion have some relevant functional consequences in the neuronal networks (properties and propagation of EA), other functional properties were not affected in contrast to what has been described in the Lis ± mouse model. For instance, enhanced excitability and epileptic activity observed in the Lis ± model (Greenwood et al.
2009), are absent in the
Lis1/sLis1 model. Interestingly, the mutation of the
Lis1/sLis1 model mimics the mutation presented by a patient with a mild lissencephalic phenotype (Fogli et al.
1999). Thus, our results point to the relationship among LisH domain alterations and less severe forms of lissencephaly. Furthermore, the fact that a homologous mutation produces a less severe phenotype in humans and also in mice suggests that this genotype–phenotype relationship might be preserved across the mammalian phylogeny, supporting the utility of murine models for this purpose.
We conclude that in the Lis1/sLis1 model the cingulate cortex has a normal overall excitability, but the epileptiform discharges evoked in conditions of disinhibition have altered properties (a lower frequency of oscillatory post-discharges) and propagate along layer 2/3 at a lower velocity. Our findings about the slower propagation of EA and the possible implication of glutamate receptors could shed light on the implication of the gene LIS1 on complex electrical responses that are generated by cortical circuits; however, given that human lissencephaly is strongly determined by cortical structural abnormalities (and our model lacks those abnormalities) it is difficult to relate our findings to those pathophysiological mechanisms underlying the clinical symptoms of lissencephaly.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.